Tel: 0113 4264300 | firstname.lastname@example.org
Arterius Limited has been awarded a research grant from the European Union (Seven Frame work Programme, FP7) for a collaborative project to develop the next generation of biodegradable coronary stent for the treatment of coronary artery disease. The project started in January 2014 with fourteen members collaborating on the project and total costs of €5.8 million.
The incidence of coronary artery disease is increasing worldwide given the growing ageing population and increased risk factors such as diabetes, obesity and hypertension. Effective therapies are needed to ensure quality long-term results for patients. New stent technologies such as biodegradable stents, that provide the temporary support to the vessel and disappear overtime, are a viable alternative to the current permanent metallic drug-eluting stents and bare metal stents.
Dr Kadem Al-Lamee, CEO at Arterius Limited will lead the commercial exploitation of the product and dissemination of the project technical results.
Dr Kadem Al-Lamee said: “Biodegradable stent technology is still in the early stages however this technology has the potential to revolutionise the stent industry and improve treatment outcomes for patients with coronary and peripheral vascular disease. In conjunction with a consortium consisting of European universities and industry, Arterius’ business strategy will to build a market leading portfolio of products, required for use in the next generation of drug eluting fully biodegradable stents”.
Arterius’ team will play a major role in collaborating with the following consortium members to achieve the technical and commercial objectives of this exciting project:
Arterius Limited, United Kingdom
The University of Westminster LBG, United Kingdom, (Scientific Coordinator is Dr. Ipsita Roy)
Ceram Limited, United Kingdom, ( Project Coordinator is Dr. Xiang Zhang)
Vornia Limited, Ireland
Spintec Engineering GmbH, Germany
Politecnico di Torino, Italy
University of Southampton, United Kingdom
Friedrich-Alexander-Universität Erlangen-Nümberg, Germany
Fundación TEKNIKER, Spain
Fraunhofer Institute for Production Technology IPA, Germany
University of Cambridge (The Chancellor, Masters and Scholars of the University), United Kingdom
University Clinic Bergmannsheil – Hospital of the Ruhr-University Bochum, Germany
Life and Device SRL, Italy
EURESCOM-European Institute for Research and Strategic Studies in Telecommunications GmbH, Germany
For further information, please contact: Dr Kadem Al-Lamee, CEO
Telephone: +44 (0) 1274 23687